Clinical trial · Interventional
RFA for Small HCC With No-touch Technique Using Octopus Electrode
Radiofrequency Ablation for Small Hepatocellular Carcinoma Using Octopus Electrode and No-touch Technique: Preliminary Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, the investigators are going to prospectively compare the clinical outcomes (technical success rate, 12 month local tumor progression rate, complication rate, tumor seeding rate) of Radiofrequency ablation (RFA) with octopus electrode and no-touch technique for Hepatocellular carcinoma (HCC) to those of RFA with conventional tumor puncture method with the same device.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Hepatocellular | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional tumor puncture RFA | Procedure | — | UNRESOLVED |
| No-touch RFA | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- No-touch RFA arm
- description
- No-touch RFA arm indicates RFA procedure using Octopus electrode and no touch technique.
- interventionNames
- Procedure: No-touch RFA
- type
- ACTIVE_COMPARATOR
- label
- Conventional tumor puncture RFA arm
- description
- Conventional tumor puncture RFA arm indicates RFA procedure using Octopus electrode and conventional tumor puncture technique.
- interventionNames
- Procedure: Conventional tumor puncture RFA
Primary outcomes (1)
- measure
- 12 month local tumor progression (LTP) rate
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Child-Pugh class A * patient with 1cm-2.5cm sized HCC * 1 or 2 HCCs * being referred for curative purpose of RFA * sign informed consent Exclusion Criteria: * maximum tumor diameter greater than 2.5cm * Child-Pugh class B or C * more than 3 HCC lesions * invisible tumor even after US/CT or US/MR fusion * presence of vascular tumor thrombosis or extrahepatic metastasis * severe coagulopathy (PLT \< 50K, PT \< 50% of normal range)
References
Publications (0)
Data not yet available